Trademark applications and grants for Shire Nps Pharmaceuticals Inc. Shire Nps Pharmaceuticals Inc has 22 trademark applications. The latest application filed is for "PREOTACT"
Patent Application | Date |
---|---|
GLP-2 FUSION POLYPEPTIDES AND USES FOR TREATING AND PREVENTING GASTROINTESTINAL CONDITIONS 20210355187 - 17/288824 NORTON; Angela ;   et al. | 2021-11-18 |
FORMULATIONS FOR IMPROVED STABILITY OF RECOMBINANT HUMAN PARATHYROID HORMONE 20210315978 - 17/264720 DIXIT; Nitin ;   et al. | 2021-10-14 |
TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY 20210236603 - 17/224761 SANGUINETTI; Elizabeth L. ;   et al. | 2021-08-05 |
TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY 20210213106 - 17/215036 SANGUINETTI; Elizabeth L. ;   et al. | 2021-07-15 |
TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY 20210213105 - 17/213534 SANGUINETTI; Elizabeth L. ;   et al. | 2021-07-15 |
NCAGE Code | 5ARX6 | SHIRE-NPS PHARMACEUTICALS, INC. |
CAGE Code | 5ARX6 | SHIRE-NPS PHARMACEUTICALS, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.